These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7561922)

  • 21. [Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins].
    Isolan GR; Ribas Filho JM; Isolan PM; Giovanini A; Malafaia O; Dini LI; Kummer A; Negrão AW
    Arq Neuropsiquiatr; 2005 Dec; 63(4):997-1004. PubMed ID: 16400419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
    Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ
    J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.
    Matsutani T; Nagai Y; Mine S; Murai H; Saeki N; Iwadate Y
    Acta Neurochir (Wien); 2009 Mar; 151(3):263-8; discussion 268. PubMed ID: 19240976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 in astrocytic tumours: an immunohistochemical study.
    Chakrabarty A; Bridges LR; Gray S
    Neuropathol Appl Neurobiol; 1996 Aug; 22(4):311-6. PubMed ID: 8875465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.
    Sarkar C; Ralte AM; Sharma MC; Mehta VS
    Br J Neurosurg; 2002 Aug; 16(4):335-42. PubMed ID: 12389885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in supratentorial WHO grade II astrocytoma in adults.
    Shinoda J; Sakai N; Nakatani K; Funakoshi T
    Br J Neurosurg; 1998 Aug; 12(4):318-24. PubMed ID: 10070423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
    Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
    Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
    Kordek R; Biernat W; Alwasiak J; Liberski PP
    Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Mastronardi L; Puzzilli F; Guiducci A
    Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
    Korkolopoulou P; Oates J; Crocker J; Edwards C
    J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
    Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
    Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
    Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
    Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
    Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L
    J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.